Highlights

array(40) {
  [0]=>
  string(4) "2049"
  ["article_id"]=>
  string(4) "2049"
  [1]=>
  string(138) "Shineco, Inc. Announces Update on its Strategic Cooperation with Regional People’s Government for Industrial Hemp Industrialization"
  ["article_title"]=>
  string(138) "Shineco, Inc. Announces Update on its Strategic Cooperation with Regional People’s Government for Industrial Hemp Industrialization"
  [2]=>
  string(166) "BEIJING, May  08, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal med"
  ["short_description"]=>
  string(166) "BEIJING, May  08, 2019  (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal med"
  [3]=>
  string(724) "

BEIJING, May 08, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company has completed seeding its industrial hemp seeding base in Heilongjiang Province following the strategic cooperation  agreement (the “Agreement”) with the Xingshan People's Government of Hegang City of Heilongjiang Province (the “Government”) for industrial hemp industrialization agreed to by the two parties in April 2019.

" ["description"]=> string(724) "

BEIJING, May 08, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company has completed seeding its industrial hemp seeding base in Heilongjiang Province following the strategic cooperation  agreement (the “Agreement”) with the Xingshan People's Government of Hegang City of Heilongjiang Province (the “Government”) for industrial hemp industrialization agreed to by the two parties in April 2019.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(200) "http://www.globenewswire.com/news-release/2019/05/08/1819454/0/en/Shineco-Inc-Announces-Update-on-its-Strategic-Cooperation-with-Regional-People-s-Government-for-Industrial-Hemp-Industrialization.html" ["blog_url"]=> string(200) "http://www.globenewswire.com/news-release/2019/05/08/1819454/0/en/Shineco-Inc-Announces-Update-on-its-Strategic-Cooperation-with-Regional-People-s-Government-for-Industrial-Hemp-Industrialization.html" [15]=> string(19) "2019-05-08 21:00:00" ["add_date"]=> string(19) "2019-05-08 21:00:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-09 16:41:16" ["create_at"]=> string(19) "2019-05-09 16:41:16" [19]=> string(0) "" ["slug"]=> string(0) "" }

Shineco, Inc. Announces Update on its Strategic Cooperation with Regional People’s

BEIJING, May 08, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Comp

array(40) {
  [0]=>
  string(4) "4570"
  ["article_id"]=>
  string(4) "4570"
  [1]=>
  string(66) "10th International Conference on Clinical and Medical Case Reports"
  ["article_title"]=>
  string(66) "10th International Conference on Clinical and Medical Case Reports"
  [2]=>
  string(167) "&#nl&#nl&#nlConference Series is delighted to organize the “10th International Conference on Clinical & Medical Case Reports” on Sep 16th -17th, 20"
  ["short_description"]=>
  string(167) "&#nl&#nl&#nlConference Series is delighted to organize the “10th International Conference on Clinical & Medical Case Reports” on Sep 16th -17th, 20"
  [3]=>
  string(531) "&#nl&#nl&#nlConference Series is delighted to organize the “10th International Conference on Clinical & Medical Case Reports” on Sep 16th -17th, 2019 at Amsterdam, Netherlands. The conference will witness an amalgamation of eminent speaker’s experts from various fields like Pathology, Medicine, medical and clinical research disciplines and is aimed to serve as a global platform for the discussion of advancements in all the fields of Clinical and Medical Case Reports.For details, please go through..."
  ["description"]=>
  string(531) "&#nl&#nl&#nlConference Series is delighted to organize the “10th International Conference on Clinical & Medical Case Reports” on Sep 16th -17th, 2019 at Amsterdam, Netherlands. The conference will witness an amalgamation of eminent speaker’s experts from various fields like Pathology, Medicine, medical and clinical research disciplines and is aimed to serve as a global platform for the discussion of advancements in all the fields of Clinical and Medical Case Reports.For details, please go through..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(98) "https://www.pharmiweb.com/event/10th-international-conference-on-clinical-and-medical-case-reports"
  ["blog_url"]=>
  string(98) "https://www.pharmiweb.com/event/10th-international-conference-on-clinical-and-medical-case-reports"
  [15]=>
  string(19) "2019-05-08 20:42:36"
  ["add_date"]=>
  string(19) "2019-05-08 20:42:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:22"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

10th International Conference on Clinical and Medical Case Reports

&#nl&#nl&#nlConference Series is delighted to organize the “10th International Conference on Clinical & Me

array(40) {
  [0]=>
  string(4) "1954"
  ["article_id"]=>
  string(4) "1954"
  [1]=>
  string(69) "National Association for Women Pharmacists to dissolve at end of 2019"
  ["article_title"]=>
  string(69) "National Association for Women Pharmacists to dissolve at end of 2019"
  [2]=>
  string(96) "The National Association of Women Pharmacists will close down its operations at the end of 2019."
  ["short_description"]=>
  string(96) "The National Association of Women Pharmacists will close down its operations at the end of 2019."
  [3]=>
  string(96) "The National Association of Women Pharmacists will close down its operations at the end of 2019."
  ["description"]=>
  string(96) "The National Association of Women Pharmacists will close down its operations at the end of 2019."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(157) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/national-association-for-women-pharmacists-to-dissolve-at-end-of-2019/20206512.article"
  ["blog_url"]=>
  string(157) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/national-association-for-women-pharmacists-to-dissolve-at-end-of-2019/20206512.article"
  [15]=>
  string(19) "2019-05-08 20:18:00"
  ["add_date"]=>
  string(19) "2019-05-08 20:18:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

National Association for Women Pharmacists to dissolve at end of 2019

The National Association of Women Pharmacists will close down its operations at the end of 2019.

array(40) {
  [0]=>
  string(4) "1895"
  ["article_id"]=>
  string(4) "1895"
  [1]=>
  string(54) "NHFOV Superior for Preventing Reintubation of Preemies"
  ["article_title"]=>
  string(54) "NHFOV Superior for Preventing Reintubation of Preemies"
  [2]=>
  string(150) "WEDNESDAY, May 8, 2019 -- Nasal high-frequency oscillatory ventilation (NHFOV) reduces reintubation by more than 50 percent in preterm infants with re"
  ["short_description"]=>
  string(150) "WEDNESDAY, May 8, 2019 -- Nasal high-frequency oscillatory ventilation (NHFOV) reduces reintubation by more than 50 percent in preterm infants with re"
  [3]=>
  string(255) "WEDNESDAY, May 8, 2019 -- Nasal high-frequency oscillatory ventilation (NHFOV) reduces reintubation by more than 50 percent in preterm infants with respiratory distress syndrome (RDS), according to a study published in the April issue of CHEST.&#nlLong..."
  ["description"]=>
  string(255) "WEDNESDAY, May 8, 2019 -- Nasal high-frequency oscillatory ventilation (NHFOV) reduces reintubation by more than 50 percent in preterm infants with respiratory distress syndrome (RDS), according to a study published in the April issue of CHEST.&#nlLong..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(183) "https://www.drugs.com/news/nhfov-superior-preventing-reintubation-preemies-82340.html?utm_source=ddc&utm_medium=rss&utm_campaign=NHFOV+Superior+for+Preventing+Reintubation+of+Preemies"
  ["blog_url"]=>
  string(183) "https://www.drugs.com/news/nhfov-superior-preventing-reintubation-preemies-82340.html?utm_source=ddc&utm_medium=rss&utm_campaign=NHFOV+Superior+for+Preventing+Reintubation+of+Preemies"
  [15]=>
  string(19) "2019-05-08 20:00:56"
  ["add_date"]=>
  string(19) "2019-05-08 20:00:56"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

NHFOV Superior for Preventing Reintubation of Preemies

WEDNESDAY, May 8, 2019 -- Nasal high-frequency oscillatory ventilation (NHFOV) reduces reintubation by more than 50 perc

array(40) {
  [0]=>
  string(4) "2108"
  ["article_id"]=>
  string(4) "2108"
  [1]=>
  string(69) "Super Saver Rate for Seattle Life Science Xchange Event Ends Tomorrow"
  ["article_title"]=>
  string(69) "Super Saver Rate for Seattle Life Science Xchange Event Ends Tomorrow"
  [2]=>
  string(150) "Grab your ticket now to attend Life Science Xchange: Closer to Convergence. Join Xconomy on June 25 at Cambia Grove in Seattle to hear the stories of "
  ["short_description"]=>
  string(150) "Grab your ticket now to attend Life Science Xchange: Closer to Convergence. Join Xconomy on June 25 at Cambia Grove in Seattle to hear the stories of "
  [3]=>
  string(362) "Grab your ticket now to attend Life Science Xchange: Closer to Convergence. Join Xconomy on June 25 at Cambia Grove in Seattle to hear the stories of local organizations taking advantage of the growing convergence of biology and data to discover, develop, and deliver healthcare innovation to patients— in the form of drugs, diagnostics, devices, […]"
  ["description"]=>
  string(362) "Grab your ticket now to attend Life Science Xchange: Closer to Convergence. Join Xconomy on June 25 at Cambia Grove in Seattle to hear the stories of local organizations taking advantage of the growing convergence of biology and data to discover, develop, and deliver healthcare innovation to patients— in the form of drugs, diagnostics, devices, […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(110) "https://xconomy.com/national/2019/05/08/super-saver-rate-for-seattle-life-science-xchange-event-ends-tomorrow/"
  ["blog_url"]=>
  string(110) "https://xconomy.com/national/2019/05/08/super-saver-rate-for-seattle-life-science-xchange-event-ends-tomorrow/"
  [15]=>
  string(19) "2019-05-08 20:00:48"
  ["add_date"]=>
  string(19) "2019-05-08 20:00:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Super Saver Rate for Seattle Life Science Xchange Event Ends Tomorrow

Grab your ticket now to attend Life Science Xchange: Closer to Convergence. Join Xconomy on June 25 at Cambia Grove in S

array(40) {
  [0]=>
  string(4) "1896"
  ["article_id"]=>
  string(4) "1896"
  [1]=>
  string(62) "Low Glucose Levels at Hospital Discharge Tied to Poor Outcomes"
  ["article_title"]=>
  string(62) "Low Glucose Levels at Hospital Discharge Tied to Poor Outcomes"
  [2]=>
  string(150) "WEDNESDAY, May 8, 2019 -- Patients with diabetes who have hypoglycemia or near-normal glucose values during the last day of hospitalization have highe"
  ["short_description"]=>
  string(150) "WEDNESDAY, May 8, 2019 -- Patients with diabetes who have hypoglycemia or near-normal glucose values during the last day of hospitalization have highe"
  [3]=>
  string(249) "WEDNESDAY, May 8, 2019 -- Patients with diabetes who have hypoglycemia or near-normal glucose values during the last day of hospitalization have higher rates of 30-day readmission and postdischarge mortality, according to a study published online..."
  ["description"]=>
  string(249) "WEDNESDAY, May 8, 2019 -- Patients with diabetes who have hypoglycemia or near-normal glucose values during the last day of hospitalization have higher rates of 30-day readmission and postdischarge mortality, according to a study published online..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(200) "https://www.drugs.com/news/low-glucose-levels-hospital-discharge-tied-poor-outcomes-82341.html?utm_source=ddc&utm_medium=rss&utm_campaign=Low+Glucose+Levels+at+Hospital+Discharge+Tied+to+Poor+Outcomes"
  ["blog_url"]=>
  string(200) "https://www.drugs.com/news/low-glucose-levels-hospital-discharge-tied-poor-outcomes-82341.html?utm_source=ddc&utm_medium=rss&utm_campaign=Low+Glucose+Levels+at+Hospital+Discharge+Tied+to+Poor+Outcomes"
  [15]=>
  string(19) "2019-05-08 20:00:48"
  ["add_date"]=>
  string(19) "2019-05-08 20:00:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Low Glucose Levels at Hospital Discharge Tied to Poor Outcomes

WEDNESDAY, May 8, 2019 -- Patients with diabetes who have hypoglycemia or near-normal glucose values during the last day

array(40) {
  [0]=>
  string(4) "1897"
  ["article_id"]=>
  string(4) "1897"
  [1]=>
  string(68) "Gestational Weight Gain Weak Predictor of Adverse Pregnancy Outcomes"
  ["article_title"]=>
  string(68) "Gestational Weight Gain Weak Predictor of Adverse Pregnancy Outcomes"
  [2]=>
  string(150) "WEDNESDAY, May 8, 2019 -- Optimal gestational weight gain has limited predictive value for adverse pregnancy outcomes, according to research published"
  ["short_description"]=>
  string(150) "WEDNESDAY, May 8, 2019 -- Optimal gestational weight gain has limited predictive value for adverse pregnancy outcomes, according to research published"
  [3]=>
  string(255) "WEDNESDAY, May 8, 2019 -- Optimal gestational weight gain has limited predictive value for adverse pregnancy outcomes, according to research published in the May 7 issue of the Journal of the American Medical Association.&#nlRomy Gaillard, M.D., Ph.D.,..."
  ["description"]=>
  string(255) "WEDNESDAY, May 8, 2019 -- Optimal gestational weight gain has limited predictive value for adverse pregnancy outcomes, according to research published in the May 7 issue of the Journal of the American Medical Association.&#nlRomy Gaillard, M.D., Ph.D.,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(215) "https://www.drugs.com/news/gestational-weight-gain-weak-predictor-adverse-pregnancy-outcomes-82343.html?utm_source=ddc&utm_medium=rss&utm_campaign=Gestational+Weight+Gain+Weak+Predictor+of+Adverse+Pregnancy+Outcomes"
  ["blog_url"]=>
  string(215) "https://www.drugs.com/news/gestational-weight-gain-weak-predictor-adverse-pregnancy-outcomes-82343.html?utm_source=ddc&utm_medium=rss&utm_campaign=Gestational+Weight+Gain+Weak+Predictor+of+Adverse+Pregnancy+Outcomes"
  [15]=>
  string(19) "2019-05-08 20:00:33"
  ["add_date"]=>
  string(19) "2019-05-08 20:00:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Gestational Weight Gain Weak Predictor of Adverse Pregnancy Outcomes

WEDNESDAY, May 8, 2019 -- Optimal gestational weight gain has limited predictive value for adverse pregnancy outcomes, a

array(40) {
  [0]=>
  string(4) "1898"
  ["article_id"]=>
  string(4) "1898"
  [1]=>
  string(62) "In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs"
  ["article_title"]=>
  string(62) "In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs"
  [2]=>
  string(150) "WEDNESDAY, May 8, 2019 -- In 2015 to 2016, 45.8 percent of the U.S. population used prescription drugs within the past 30 days, according to a May dat"
  ["short_description"]=>
  string(150) "WEDNESDAY, May 8, 2019 -- In 2015 to 2016, 45.8 percent of the U.S. population used prescription drugs within the past 30 days, according to a May dat"
  [3]=>
  string(252) "WEDNESDAY, May 8, 2019 -- In 2015 to 2016, 45.8 percent of the U.S. population used prescription drugs within the past 30 days, according to a May data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health..."
  ["description"]=>
  string(252) "WEDNESDAY, May 8, 2019 -- In 2015 to 2016, 45.8 percent of the U.S. population used prescription drugs within the past 30 days, according to a May data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(186) "https://www.drugs.com/news/2015-2016-45-8-percent-u-s-population-rx-82346.html?utm_source=ddc&utm_medium=rss&utm_campaign=In+2015+to+2016%2C+45.8+Percent+of+U.S.+Population+Used+Rx+Drugs"
  ["blog_url"]=>
  string(186) "https://www.drugs.com/news/2015-2016-45-8-percent-u-s-population-rx-82346.html?utm_source=ddc&utm_medium=rss&utm_campaign=In+2015+to+2016%2C+45.8+Percent+of+U.S.+Population+Used+Rx+Drugs"
  [15]=>
  string(19) "2019-05-08 20:00:12"
  ["add_date"]=>
  string(19) "2019-05-08 20:00:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

WEDNESDAY, May 8, 2019 -- In 2015 to 2016, 45.8 percent of the U.S. population used prescription drugs within the past 3

array(40) {
  [0]=>
  string(4) "1899"
  ["article_id"]=>
  string(4) "1899"
  [1]=>
  string(61) "Percutaneous Ablation in Liver Cancer Tied to Better Outcomes"
  ["article_title"]=>
  string(61) "Percutaneous Ablation in Liver Cancer Tied to Better Outcomes"
  [2]=>
  string(150) "WEDNESDAY, May 8, 2019 -- For patients with hepatocellular carcinoma (HCC), percutaneous liver ablation interventions are associated with lower in-hos"
  ["short_description"]=>
  string(150) "WEDNESDAY, May 8, 2019 -- For patients with hepatocellular carcinoma (HCC), percutaneous liver ablation interventions are associated with lower in-hos"
  [3]=>
  string(252) "WEDNESDAY, May 8, 2019 -- For patients with hepatocellular carcinoma (HCC), percutaneous liver ablation interventions are associated with lower in-hospital mortality, length of stay (LOS), and hospitalization costs compared with surgical procedures,..."
  ["description"]=>
  string(252) "WEDNESDAY, May 8, 2019 -- For patients with hepatocellular carcinoma (HCC), percutaneous liver ablation interventions are associated with lower in-hospital mortality, length of stay (LOS), and hospitalization costs compared with surgical procedures,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(198) "https://www.drugs.com/news/percutaneous-ablation-liver-cancer-tied-better-outcomes-82337.html?utm_source=ddc&utm_medium=rss&utm_campaign=Percutaneous+Ablation+in+Liver+Cancer+Tied+to+Better+Outcomes"
  ["blog_url"]=>
  string(198) "https://www.drugs.com/news/percutaneous-ablation-liver-cancer-tied-better-outcomes-82337.html?utm_source=ddc&utm_medium=rss&utm_campaign=Percutaneous+Ablation+in+Liver+Cancer+Tied+to+Better+Outcomes"
  [15]=>
  string(19) "2019-05-08 20:00:05"
  ["add_date"]=>
  string(19) "2019-05-08 20:00:05"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Percutaneous Ablation in Liver Cancer Tied to Better Outcomes

WEDNESDAY, May 8, 2019 -- For patients with hepatocellular carcinoma (HCC), percutaneous liver ablation interventions ar

array(40) {
  [0]=>
  string(4) "1867"
  ["article_id"]=>
  string(4) "1867"
  [1]=>
  string(59) "Pfizer's Vyndaqel, Vyndamax win US nod for rare disease"
  ["article_title"]=>
  string(59) "Pfizer's Vyndaqel, Vyndamax win US nod for rare disease"
  [2]=>
  string(142) "The approval is based on a clinical trial which showed that after an average of 30 months, the survival rate was higher in the Vyndaqel group."
  ["short_description"]=>
  string(142) "The approval is based on a clinical trial which showed that after an average of 30 months, the survival rate was higher in the Vyndaqel group."
  [3]=>
  string(142) "The approval is based on a clinical trial which showed that after an average of 30 months, the survival rate was higher in the Vyndaqel group."
  ["description"]=>
  string(142) "The approval is based on a clinical trial which showed that after an average of 30 months, the survival rate was higher in the Vyndaqel group."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(94) "http://www.pharmatimes.com/news/pfizers_vyndaqel,_vyndamax_win_us_nod_for_rare_disease_1287186"
  ["blog_url"]=>
  string(94) "http://www.pharmatimes.com/news/pfizers_vyndaqel,_vyndamax_win_us_nod_for_rare_disease_1287186"
  [15]=>
  string(19) "2019-05-08 19:56:46"
  ["add_date"]=>
  string(19) "2019-05-08 19:56:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:48"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:48"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Pfizer's Vyndaqel, Vyndamax win US nod for rare disease

The approval is based on a clinical trial which showed that after an average of 30 months, the survival rate was higher

array(40) {
  [0]=>
  string(4) "2148"
  ["article_id"]=>
  string(4) "2148"
  [1]=>
  string(71) "Nelipak Healthcare Packaging announces partnership with the Optel Group"
  ["article_title"]=>
  string(71) "Nelipak Healthcare Packaging announces partnership with the Optel Group"
  [2]=>
  string(150) "Nelipak Healthcare Packaging, a global provider of custom thermoformed packaging has partnered with the Optel Group, a global provider of vision inspe"
  ["short_description"]=>
  string(150) "Nelipak Healthcare Packaging, a global provider of custom thermoformed packaging has partnered with the Optel Group, a global provider of vision inspe"
  [3]=>
  string(238) "Nelipak Healthcare Packaging, a global provider of custom thermoformed packaging has partnered with the Optel Group, a global provider of vision inspection and traceability systems  to bring a new seal inspection technology to the market."
  ["description"]=>
  string(238) "Nelipak Healthcare Packaging, a global provider of custom thermoformed packaging has partnered with the Optel Group, a global provider of vision inspection and traceability systems  to bring a new seal inspection technology to the market."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/nelipak-healthcare-packaging-announces-partnership-with-the-/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/nelipak-healthcare-packaging-announces-partnership-with-the-/"
  [15]=>
  string(19) "2019-05-08 19:16:46"
  ["add_date"]=>
  string(19) "2019-05-08 19:16:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:39"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Nelipak Healthcare Packaging announces partnership with the Optel Group

Nelipak Healthcare Packaging, a global provider of custom thermoformed packaging has partnered with the Optel Group, a g

array(40) {
  [0]=>
  string(4) "2109"
  ["article_id"]=>
  string(4) "2109"
  [1]=>
  string(60) "Goldfinch Bio Lands $55M From Gilead in Kidney Drug R&D Pact"
  ["article_title"]=>
  string(60) "Goldfinch Bio Lands $55M From Gilead in Kidney Drug R&D Pact"
  [2]=>
  string(150) "Goldfinch Bio set out to build a database of patients with kidney diseases, which it could study to understand the biology and genetics of kidney diso"
  ["short_description"]=>
  string(150) "Goldfinch Bio set out to build a database of patients with kidney diseases, which it could study to understand the biology and genetics of kidney diso"
  [3]=>
  string(348) "Goldfinch Bio set out to build a database of patients with kidney diseases, which it could study to understand the biology and genetics of kidney disorders in order to develop better drugs. The biotech startup is making headway on its research and its approach now has some outside validation. Gilead Sciences is partnering with Goldfinch […]"
  ["description"]=>
  string(348) "Goldfinch Bio set out to build a database of patients with kidney diseases, which it could study to understand the biology and genetics of kidney disorders in order to develop better drugs. The biotech startup is making headway on its research and its approach now has some outside validation. Gilead Sciences is partnering with Goldfinch […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(97) "https://xconomy.com/boston/2019/05/08/goldfinch-bio-lands-55m-from-gilead-in-kidney-drug-rd-pact/"
  ["blog_url"]=>
  string(97) "https://xconomy.com/boston/2019/05/08/goldfinch-bio-lands-55m-from-gilead-in-kidney-drug-rd-pact/"
  [15]=>
  string(19) "2019-05-08 19:00:16"
  ["add_date"]=>
  string(19) "2019-05-08 19:00:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Goldfinch Bio Lands $55M From Gilead in Kidney Drug R&D Pact

Goldfinch Bio set out to build a database of patients with kidney diseases, which it could study to understand the biolo